StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pure Bioscience's price to book ratio was 49.3× on Nov 30, 2023, against 4.3× a year earlier. Over the last 5 years it ranged from 3.0× to 129.9×, with a median of 13.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Nov 30, 202349.3×+46.4
2022Dec 30, 20223.0×−3.2
2021Dec 31, 20216.1×−7.9
2020Dec 31, 202014.0×−3.2
2019Dec 31, 201917.1×+3.2
2018Dec 31, 201813.9×−0.3
2017Dec 29, 201714.2×−1.7
2016Dec 30, 201615.9×−209.7
2015Dec 31, 2015225.5×+222.1
2014Dec 31, 20143.5×−126.6
2013Dec 31, 2013130.1×+127.9
2012Dec 31, 20122.2×−2.3
2011Dec 30, 20114.5×–

More Pure Bioscience figures

See a number that looks wrong?